FDA Approves First Orexin-Targeting Narcolepsy Type 1 Drug
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Takeda Pharmaceuticals America’s Orzeyful tablets for adults with narcolepsy type 1, making it the first treatment cleared to address the …
FDA Approves First Orexin-Targeting Narcolepsy Type 1 Drug Read More